Sulanemadlin

DB17285InvestigationalProtein Based Therapies

Sulanemadlin: Overview.

Mechanism: Pharmacologically active on E3 ubiquitin-protein ligase Mdm2 and Protein Mdm4
Curator reviewed
Code names: ALRN-6924

Resolves to

Compound

Targets

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

6Clinical trialsPhase, status and sponsor resolved per trial

10+ReferencesStructured and connected to the statements they support

Which drugs share a target with Sulanemadlin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.